Prevention of Post-Operative Adhesions after Flexor Tendon Repair with Acellular Dermal Matrix .
Prevention of postoperative adhesions after flexor tendon repair with acellular dermal matrix in Zones III, IV, and V of the hand: A randomized controlled (CONSORT-compliant) trial.
Medicine (Baltimore). 2022 Jan 21;101(3): e28630.Twenty five patients with an acute single-digit flexor tendon injury in Zone III, IV or V undergoing a flexor tendon repair were randomized to receive acellular dermal matrix (n=13) or no additional treatment (n=12) for the prevention of post-operative flexor tendon adhesion and facilitation of functional recovery. Outcomes of interest included functional outcomes (Buck-Gramcko II score), patient satisfaction, and the incidence of complications. Outcomes were assessed at 12 months post-operation. Results revealed significantly better functional scores and patient satisfaction scores in the acellular dermal matrix group. There were no differences in complications between the two groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
